Signal regulatory protein-α interacts with the insulin receptor contributing to muscle wasting in chronic kidney disease

Kidney International

Volumn 84, Issue 2, 2013, Pages 308-316

  Thomas, Sandhya S ^a   Dong, Yanjun ^a   Zhang, Liping ^a   Mitch, William E ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Chronic kidney disease; Inflammation; Insulin resistance; Metabolism

Indexed keywords

CYTOKINE; GLUCOSE; GLYCOPROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; MEMBRANE PROTEIN; MESSENGER RNA; REGULATOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; GLUCOSE INTOLERANCE; IMMUNOPRECIPITATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; MICROARRAY ANALYSIS; MOUSE; MUSCLE ATROPHY; MUSCLE FIBER MEMBRANE; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; SKELETAL MUSCLE;

ANIMALS; CELL LINE; CYTOKINES; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; GLUCOSE INTOLERANCE; I-KAPPA B KINASE; INFLAMMATION MEDIATORS; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; MICE; MICE, INBRED C57BL; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; MUSCULAR ATROPHY; NEPHRECTOMY; NF-KAPPA B; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, INSULIN; RECEPTORS, IMMUNOLOGIC; RENAL INSUFFICIENCY, CHRONIC; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION; TYROSINE;

EID: 84881162284     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2013.97     Document Type: Article

References (38)

1. Fliser D, Pacini G, Engelleiter R et al. Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. Kidney Int 1998; 53: 1343-1347. (Pubitemid 28316896)
2. Kobayashi S, Maesato K, Moriya H et al. Insulin resistance in patients with chronic kidney disease. Am J Kid Dis 2005; 45: 275-280. (Pubitemid 40431052)
3. DeFronzo RA, Alvestrand A, Smith D et al. Insulin resistance in uremia. J Clin Invest 1981; 67: 563-568. (Pubitemid 11141740)
4. Smith D, DeFronzo RA. Insulin resistance in uremia mediated by postbinding defects. Kidney Int 1982; 22: 54-62. (Pubitemid 12091218)
5. May RC, Kelly RA, Mitch WE. Mechanisms for defects in muscle protein metabolism in rats with chronic uremia: the influence of metabolic acidosis. J Clin Invest 1987; 79: 1099-1103.
6. Bailey JL, Price SR, Zheng B et al. Chronic kidney disease causes defects in signaling through the insulin receptor substrate/phosphatidylinositol 3-kinase/Akt pathway: implications for muscle atroply. J Am Soc Nephrol 2006; 17: 1388-1394. (Pubitemid 43673419)
7. Hu Z, Wang H, Lee IH et al. Endogenous glucocorticoids and impaired insulin signaling are both required to stimulate muscle wasting under pathophysiological conditions in mice. J Clin Invest 2009; 119: 7650-7659.
8. Zhang L, Du J, Hu Z et al. IL-6 and serum amyloid A synergy mediates angiotensin II-induced muscle wasting. J AmSoc Nephrol 2009; 20: 604-612.
9. Cai D, Yuan M, Frantz DF et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med 2005; 11: 183-190. (Pubitemid 40321354)
10. Friedman JE, Dohm GL, Elton CW et al. Muscle insulin resistance in uremic humans: glucose transport, glucose transporters, and insulin receptors. Am J Physiol 1991; 261: E87-E94.
11. Cecchin F, Ittoop O, Sinha MK et al. Insulin resistance in uremia: insulin receptor kinase activity in liver and muscle from chronic uremic rats. Am J Physiol 1988; 254: E394-E401.
12. Du J, Wang X, Meireles CL et al. Activation of caspase 3 is an initial step triggering muscle proteolysis in catabolic conditions. J Clin Invest 2004; 113: 115-123. (Pubitemid 38541638)
13. Bailey JL, Wang X, England BK et al. The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent, ubiquitin-proteasome pathway. J Clin Invest 1996; 97: 1447-1453. (Pubitemid 26097034)
14. Lee SW, Dai G, Hu Z et al. Regulation of muscle protein degradation: coordinated control of apoptotic and ubiquitin-proteasome systems by phosphatidylinositol 3 kinase. J Am Soc Nephrol 2004; 15: 1537-1545. (Pubitemid 38679678)
15. Zhang L, Wang XH, Wang H et al. Satellite cell dysfunction and impaired IGF-1 signaling contribute to muscle atrophy in chronic kidney disease. J Am Soc Nephrol 2010; 21: 419-427.
16. Shoelson S, Leo J, Goldfine A. Inflammation and insulin resistance. J Clin Invest 2006; 116: 1793-1801. (Pubitemid 44033299)
17. Niwa T, Tsukushi S, Ise M et al. Indoxyl sulfate and progression of renal failure-effects of a low-protein diet and oral sorbent on indoxyl sulfate production in uremic rats and undialyzed uremic patients. Min Elect Metab 1997; 23: 179-184. (Pubitemid 27475340)
18. D'Apolito M, Du X, Zong H et al. Urea-induced ROS generation causes insulin resistance in mice with chronic renal failure. J Clin Invest 2010; 120: 203-213.
19. Rigalleau V, Blanchetier V, Combe C et al. A low-protein diet improves insulin sensitivity of endogenous glucose production in predialytic uremic patients. Am J Clin Nutr 1997; 65: 1512-1516. (Pubitemid 27187766)
20. Hotamisligil GS, Peraldi P, Budavari A et al. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-a- and obesity-induced insulin resistance. Sci 1996; 271: 665-668. (Pubitemid 26052915)
21. Zhang L, Rajan V, Lin E et al. Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease. FASEB J 2011; 25: 1653-1663.
22. Giorgino F, Pedrini MT, Matera L et al. Specific increase in p85a expression in response to dexamethasone is associated with inhibition of insulin-like growth factor-1 stimulated phophatidylinositol 3-kinase activity in cultured muscle cells. J Biol Chem 1997; 272: 7455-7463. (Pubitemid 27166458)
23. Ding H, Gao X-L, Hirschberg R et al. Impaired actions of insulin-like growth factor-1 on protein synthesis and degradation in skeletal muscle of rats with chronic renal failure: Evidence for a postreceptor defect. J Clin Invest 1996; 97: 1064-1075. (Pubitemid 26074153)
24. Kharitonenkov A, Chen Z, Sures I et al. A family of proteins that inhibit signalling through tyrosine kinase receptors. Nature 1997; 386: 181-186. (Pubitemid 27131446)
25. Fujioka Y, Matozaki T, Noguchi T et al. A novel membrane glycoprotein, SHPS-1, that binds the SH2-domain-containing protein tyrosine phosphatase SHP-2 in response to mitogens and cell adhesion. Mol Cell Biol 1996; 16: 6887-6899. (Pubitemid 26389748)
26. Nandi A, Kitamura Y, Kahn CR et al. Mouse models of insulin resistance. Physiol Rev 2004; 84: 623-647. (Pubitemid 38365494)
27. Szeto CC, Kwan BC, Chow KM et al. Endotoxemia is related to systemic inflammation and atherosclerosis in peritoneal dialysis patients. Clin J Am Soc Nephrol 2008; 3: 431-436.
28. McIntyre CW, Harrison LE, Eldehni MT et al. Circulating endotoxemia: a novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease. Clin J Am Soc Nephrol 2011; 6: 133-141.
29. Du J, Mitch WE, Wang X et al. Glucocorticoids induce proteasome C3 subunit expression in L6 muscle cells by opposing the suppression of its transcription by NF-kB. J Biol Chem 2000; 275: 19661-19666. (Pubitemid 30441561)
30. Ghosh S, Hayden MS. New regulators of NF-kappaB in inflammation. Nat Rev Immunol 2008; 8: 837-848.
31. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993; 259: 87-91. (Pubitemid 23036092)
32. Feinstein R, Kanety H, Papa MZ et al. Tumor necrosis factor-a suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J Biol Chem 1993; 268: 26055-26058.
33. Chen Y, Sun D, Krishnamurthy VM et al. Endotoxin attenuates growth hormone-induced hepatic insulin-like growth factor I expression by inhibiting JAK2/STAT5 signal transduction and STAT5b DNA binding. Am J Physiol Endocrinol Metab 2007; 292: E1856-E1862. (Pubitemid 47084724)
34. Cai D, Frantz JD, Tawa NE et al. IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell 2004; 119: 285-298. (Pubitemid 39360909)
35. Maile LA, Clemmons DR. Regulation of insulin-like growth factor I receptor dephosphorylation by SHPS-1 and the tyrosine phosphatase SHP-2. J Biol Chem 2002; 277: 8955-8960. (Pubitemid 34952967)
36. Mitsuhashi H, Yoshikawa A, Sasagawa N et al. Denervation enhances the expression of SHPS-1 in rat skeletal muscle. J Biochem 2005; 137: 495-502. (Pubitemid 40806048)
37. Tzanno-Martins C, Azevedo LS, Orii N et al. The role of experimental chronic renal failure and aluminium intoxication in cellular immune response. Nephrol Dial Transplant 1996; 11: 474-480. (Pubitemid 26092786)
38. Zhang L, Cheng J, Ma Y et al. Dual pathways for nuclear factor kappaB activation by angiotensin II in vascular smooth muscle: phosphorylation of p65 by IkappaB kinase and ribosomal kinase. Circ Res 2005; 97: 975-982. (Pubitemid 41668910)